ConCallIQ
Go Pro
AKUMSDRUGSPHARMACEUTICAL Healthcare 15 May 2026

Akums Drugs & Pharmaceuticals Ltd — Q4 FY26

Akums Drugs reported a strong Q4 FY26 with consolidated revenue of ₹1,158 crore (+9.7% YoY) and adjusted EBITDA of ₹152 crore (+61.6% YoY), driven by robust CDMO volume growth o...

bullish high
Compare with...
Revenue ₹1,158 Cr +9.7%
EBITDA ₹152 Cr +61.6%
PAT ₹81 Cr
EBITDA Margin 13.1% +420bps
Duration 63 min
Read Time 1 min read

✓ Verified against BSE filing

Questions answered59%
Questions audited11
Evaded / deflected2
Numbers vs filingContradicted
Claim Ledger

Did management answer the analysts?

Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.

Partial answer High priority

Which internal capabilities are least scalable for regulated market ramp-up?

Asked by Sil Kapoor, Antifragile Thinking

Management listed existing capabilities but did not identify which is least scalable.

did not identify least scalable capabilitylisted existing strengths instead
Read the exchange
Question
as your European and regulated market business ramps, which is specific internal capabilities currently least scalable? Is it regulatory filing throughput or quality systems or tech transfer?
Sajill (management)
we already serve large Indian customers and MNC's Indian markets who themselves have a strict K sheet... we received the first European GMP approval way back in 22... plan 3 also received an visa approval this year
Evasive High priority

What is net effect on gross margin from negative and positive loops?

Asked by Sil Kapoor, Antifragile Thinking

Management did not quantify net effect, only described pass-through and R&D investment.

no net effect quantifiedgeneric pass-through explanation
Read the exchange
Question
what will be the net effect of one negative loop which is a cyclical loop... and the other one is much more structural loop which is a positive loop... what is the net effect on the gross margin in a nutshell?
Sajill (management)
as a business model it's a pass through business model. So whatever is the cost of input material gets passed on as part of a CDMO contracts... we have been investing over 100 crores in our R&D... we can gradually move up our gross margins.
Partial answer High priority

What drives volume variance >25% and will price variance reverse?

Asked by Adja Sher, Incred Asset Management

Management attributed growth to existing customers but did not explain why volume surged.

no specific driver identifiedoutlook vague
Read the exchange
Question
last two quarters the volume variance has been north of 25%. What is driving this and what is your outlook... price variance has been negative 3.5%... will this reverse going forward?
Sajill (management)
this is primarily led from existing customers only... increased demand for existing brands... similar double digit growth is also visible as we sit in May for the Q1... API prices have slightly gone up single high digits
Partial answer Medium priority

Outlook for trade generics and API business, and tax rate for FY27?

Asked by Adja Sher, Incred Asset Management

Management gave qualitative outlook but no specific revenue or profit targets.

no specific numbers for trade genericstax rate range given
Read the exchange
Question
how do you see the trade generate in API business for FI27 and beyond and a question on the tax rate accepted for FI27.
Sajill (management)
trade genic... is expected to remain at similar levels of revenue with similar levels of aida... API... we are hopeful we should do much better... tax rate... 29 on phone and overall is something we can build into our business models
Answered High priority

Why did CDMO margins expand to 14.4% despite adverse product mix?

Asked by Pravin Jaman, Aventus Park

Management explained that prior year Q4 had low margins due to provisions and mix, so current Q4 is normal.

Read the exchange
Question
in CDMO for Q4 SI26, our margins have expanded to 14.4%. Even though we had a product mix base which was diverse... how could this adverse mix improve our margins this quarter?
Sajill (management)
Q4 of 25 was an year where we had significant dip in aa driven again by the product portfolio and some year end provisions... in Q4 we had less of those low margin product and hence this looks to be an regular quarter.
Declined Medium priority

Has Schedule M implementation improved visibility or customer inquiries?

Asked by Pravin Jaman, Aventus Park

Management explicitly declined to answer due to lack of visibility.

refused to answer
Read the exchange
Question
the deadline has passed and inspections should have started... have we seen any visibility improvement... customers approaching us on this angle due to MSME's schedule M getting impact implemented?
Sajill (management)
I will like to skip this question because honestly we have no visibility on ground of how the government plans to roll this out.
Partial answer High priority

What overall CDMO revenue growth and margins expected this year?

Asked by Ankurkumar, Alpha Capital

Management gave volume growth for H1 but no revenue or margin numbers.

no specific revenue growth numberonly H1 visibility
Read the exchange
Question
what kind of overall revenue growth are we expecting this year? ... overall what kind of revenue numbers and margins are we expecting?
Sajill (management)
we have visibility for 45 to 60 days of our revenue book... we expect a double digit volume growth right so while H2 still has to be seen... Similar margin profile what we currently have?
Answered Low priority

Purpose of land lease deed in Haridwar and expansion plans?

Asked by Rohit Banani, Vij Global

Management explained the land is for capacity expansion and utility support.

Read the exchange
Question
execution of lease deed which we have done for land in Haiti. I wanted to know the purpose of you know this execution and expansion plans from this land in future.
Sajill (management)
this is simply one of those activities we will need for expansion of our capacities as well as building utility supports and so on.
Answered High priority

Expected annual revenue from European contract of 200 million euros?

Asked by Rohit Banani, Vij Global

Management gave specific annual revenue of 35 million euros for the contract.

Read the exchange
Question
European contract of 200 million euros. How much of this is expected from the first year? Will it be a 40 million euro commitment every year?
Sajill (management)
once we start we will have almost a 35 million euro on a matt basis... 35 for the next 6 years till 2032.
Answered Medium priority

Why did international branded business revenue decline but margins improve to 28%?

Asked by Achel Mahishwari, Razer Investments

Management explained margin improvement due to marketing focus and forex gains.

Read the exchange
Question
international branded business side... revenues have seen a sharp decline but the margins have improved to 28%. Is there a reason for that?
Sajill (management)
we are focusing on marketing of brands rather than just pure B2B play... also we got some benefits of the US so since it's USD we got some benefits from the forex gain... gross margins to be up by over 3 and a half 4%.
Answered Medium priority

What was capex for FY26 and target for this year?

Asked by Dia, Safar Capital

Management provided specific capex numbers for FY26 and target for FY27.

Read the exchange
Question
What was the KX for FI26 and how much are we going to spend in this year?
Sajill (management)
FYI26 we did a capex of 222 crores and this year we are targeting to keep our capex to a 300 crores.
Partial answer High priority

Will CDMO margins improve to 15-16% with new contracts?

Asked by Nitesh, Christ Capital

Management agreed margins would improve but did not quantify to 15-16%.

no specific margin targetvague improvement
Read the exchange
Question
these contracts will effectively have... better margin... do we see a CDMO margin which has been in the 13 to 14% level improve to a 15 16% level.
Sajill (management)
We can think through that the base margins for the business once both of these contracts are in full swing will improve.
Quantitative claims vs filed numbers
ClaimManagement saidFilingVerdict
CDMO margin in Q4 FY26 was 14.4% 14.4% 13.1% Overstated vs filing

Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.